Product NDC: | 0338-6011 |
Proprietary Name: | Milrinone Lactate in Dextrose |
Non Proprietary Name: | MILRINONE LACTATE |
Active Ingredient(s): | 200 ug/mL & nbsp; MILRINONE LACTATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-6011 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075834 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080602 |
Package NDC: | 0338-6011-37 |
Package Description: | 200 mL in 1 BAG (0338-6011-37) |
NDC Code | 0338-6011-37 |
Proprietary Name | Milrinone Lactate in Dextrose |
Package Description | 200 mL in 1 BAG (0338-6011-37) |
Product NDC | 0338-6011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MILRINONE LACTATE |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20080602 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | MILRINONE LACTATE |
Strength Number | 200 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |